Cyslabdan
| Code | Size | Price |
|---|
| TAR-T27111-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T27111-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
Cyslabdan inhibits the synthesis of Pentaglycine Interpeptide Bridge.
CAS:
956507-17-8
Molecular Weight:
467.67
Purity:
0.98
SMILES:
[H][C@@]12C[C@H](O)[C@](O)(CSC[C@H](NC(C)=O)C(O)=O)[C@H](C\C=C(/C)C=C)[C@@]1(C)CCCC2(C)C
References
Tak? A, Matsumoto A, ?mura S, Takahashi Y. Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov., producing lactacystin and cyslabdan, respectively. J Antibiot (Tokyo). 2015 Nov;68(11):719. doi: 10.1038/ja.2015.89. PubMed PMID: 26612144.
Tomoda H. New Approaches to Drug Discovery for Combating MRSA. Chem Pharm Bull (Tokyo). 2016;64(2):104-11. doi: 10.1248/cpb.c15-00743. Review. PubMed PMID: 26833438.
Tak? A, Matsumoto A, ?mura S, Takahashi Y. Corrigendum: Streptomyces lactacystinicus sp. nov. and Streptomyces cyslabdanicus sp. nov., producing lactacystin and cyslabdan, respectively. J Antibiot (Tokyo). 2017 Jan;70(1):113. doi: 10.1038/ja.2016.103. PubMed PMID: 28053352.
Ohtawa M, Hishinuma Y, Takagi E, Yamada T, Ito F, Arima S, Uchida R, Kim YP, ?mura S, Tomoda H, Nagamitsu T. Synthesis and Structural Revision of Cyslabdan. Chem Pharm Bull (Tokyo). 2016;64(9):1370-7. doi: 10.1248/cpb.c16-00382. PubMed PMID: 27581641.